Flavoxate
![Tallman Lettering. Project Report [Internet]](http://data.docslib.org/img/264x/31a4c7f18aa9f211a0c94a5f6c591ee3.webp)
Top View
- Antihistamine Prior Authorization Review
- Prescribing Focus
- Biodrugs Potentially Harmful Medication Use and Decline In
- 3703-3712-Flavoxate in the Symptomatic Treatment of Overactive Bladder: a Meta-Analysis
- Compound Name
- Patients with Dementia and Receiving Tricyclic Antidepressants Or Anticholinergic Agents
- Dennis A. Bennett
- RX Formulary E1/E4 Drug List PBCBSAK
- Scheduling of Medicines) GN
- Muscarinic Acetylcholine Receptor
- Anticholinergic Burden Scale
- Overactive Bladder Agents
- Flavoxate: Present and Future
- Report and Evidence Tables
- (12) United States Patent (10) Patent No.: US 6,482,837 B1 Wood (45) Date of Patent: Nov
- Attachment 2
- (12) United States Patent (10) Patent No.: US 8.481,518 B2 Wood (45) Date of Patent: Jul
- Center Study to Evaluate the Efficacy, Safety, and Tolerability